Early and Persistent Dysphagia Relief Predicts Tumor Response in Esophageal Squamous Cell Carcinoma Patients Treated with Immunochemotherapy.
Shujie HuangYong TangHansheng WuQiuling ShiJiming TangXiaosong BenDongkun ZhangLiang XieHaiyu ZhouGang ChenSichao WangZhen GaoZefeng XieRixin ChenGuibin QiaoPublished in: Annals of surgical oncology (2023)
The current study demonstrated that a longitudinal patient-reported outcome (PRO) was an easily obtained, cost-effective, and noninvasive tool for predicting tumor responses to neoadjuvant immunochemotherapy.